Nigeria this week added a rotavirus vaccine to its national program that is expected to prevent 50,000 deaths of children per year (Unsplash) 
Medicine

Nigeria: Rotavirus Vaccine Programs made National amid Shortfalls

Nigeria this week added a rotavirus vaccine to its national program that is expected to prevent 50,000 deaths of children per year from the diarrheal disease.

MedBound Times

Nigeria this week added a rotavirus vaccine to its national program that is expected to prevent 50,000 deaths of children per year from the diarrheal disease. But the launch comes amid shortages of the vaccine in countries such as Cameroon, Kenya, Senegal and Tanzania.

The launch coincided with the commemoration of Africa Vaccination Week. Officials from the World Health Organization, the United Nations children's agency, as well as Nigeria's Health Ministry, attended the launch in the capital.

During the event, many young children received the vaccine for free, while authorities urged citizens to embrace the measure.

During the event, many young children received the vaccine for free, while authorities urged citizens to embrace the measure (Unsplash)

"They'll get the opportunity of taking it when they're taking other vaccines,” said Faisal Shuaib, executive director of the National Primary Health Care Development Agency. “We need to seize this opportunity — mothers, caregivers — so that our children will be protected from this virus."

Rotavirus is the most common cause of diarrheal disease in children under 5 years old. WHO says that globally, up to 200,000 children die each year from the disease.

Authorities say the oral vaccine could prevent up to a third of severe diarrhea cases in Nigeria. WHO country representative Walter Kazadi Mulombo also attended the launch.

Authorities say the oral vaccine could prevent up to a third of severe diarrhea cases (Unsplash)

"The introduction of the rotavirus vaccine provides the opportunity to reduce the number of children dying every day from diarrheal disease caused by rotavirus,” he said.

But this month, pharmaceutical giant GlaxoSmithKline said manufacturing challenges had led to a shortfall of 4 million doses of the rotavirus this year, as well as delays in delivery.

According to GAVI-the Vaccine Alliance, the company already said it would reduce deliveries of the rotavirus vaccine by 10 million a year between 2022 and 2028.

Moses Njoku, a research fellow at Nigeria’s National Institute for Pharmaceutical Research and Development, said a shortfall should not be a challenge to Nigeria.

Njoku also said authorities must take delivery of the rotavirus vaccines in batches to avoid waste (Unsplash)

Njoku also said authorities must take delivery of the rotavirus vaccines in batches to avoid waste.

"If care is not taken, they will not be imported at the right time,” he said, adding that some might ship with little time left before an expiration date. “So, eventually you won't even use up to 10,000 doses and you have paid the money. The supply chain management system is also very poor."

For now, authorities will be trying to get as many children vaccinated as possible. (NS/VOA)

Diwali Celebrations Turn Toxic: 69% of Families in Delhi Affected by Air Pollution

Suni Lee’s Journey of Triumph: Overcoming Kidney Disease and Defying the Odds to Win Olympic Medals

AIOCD Warns Against Swiggy, PharmEasy’s 10-Minute Medicine Delivery Partnership

NMC Defends Removal of Respiratory Medicine from MBBS Curriculum Amid Court Proceedings

Marylanders To Vote on Expansive ‘Right to Reproductive Freedom’